169 related articles for article (PubMed ID: 27108868)
1. Pyoderma gangrenosum after trauma in a dog.
Nagata N; Yuki M; Asahina R; Sakai H; Maeda S
J Vet Med Sci; 2016 Sep; 78(8):1333-7. PubMed ID: 27108868
[TBL] [Abstract][Full Text] [Related]
2. Neutrophilic dermatosis resembling pyoderma gangrenosum in a dog with polyarthritis.
Bardagí M; Lloret A; Fondati A; Ferrer L
J Small Anim Pract; 2007 Apr; 48(4):229-32. PubMed ID: 17381769
[TBL] [Abstract][Full Text] [Related]
3. Canine pyoderma gangrenosum: a case series of two dogs.
Simpson DL; Burton GG; Hambrook LE
Vet Dermatol; 2013 Oct; 24(5):552-e132. PubMed ID: 23931071
[TBL] [Abstract][Full Text] [Related]
4. Ulcerative neutrophilic dermatitis resembling human bromoderma in a dog.
Dedola C; Gallucci A; Ibba F; Ennas F; Porcellato I; Brachelente C
J Small Anim Pract; 2022 Apr; 63(4):331-335. PubMed ID: 34431097
[TBL] [Abstract][Full Text] [Related]
5. Extensive fatal Pyoderma gangrenosum in a dog after drug exposure.
Schaefer L; Kloß E; Henrich M; Thom N
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2023 Oct; 51(5):361-367. PubMed ID: 37956667
[TBL] [Abstract][Full Text] [Related]
6. Canine pyoderma gangrenosum with recurring skin lesions of unknown origin and splenic involvement.
Kang JH; Yoon JH; Kim YB; Hwang CY
Vet Dermatol; 2019 Aug; 30(4):359-e105. PubMed ID: 31090152
[TBL] [Abstract][Full Text] [Related]
7. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
8. Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases.
Marzano AV; Cugno M; Trevisan V; Fanoni D; Venegoni L; Berti E; Crosti C
Clin Exp Immunol; 2010 Oct; 162(1):100-7. PubMed ID: 20636397
[TBL] [Abstract][Full Text] [Related]
9. Rare association of pyoderma gangrenosum and palmoplantar pustulosis: a case report and review of the previous works.
Ohtsuka M; Yamamoto T
J Dermatol; 2014 Aug; 41(8):732-5. PubMed ID: 24986043
[TBL] [Abstract][Full Text] [Related]
10. PAPA Syndrome: Challenges in Achieving Long-Term Remission.
Smajlović H; Prohić A
Acta Dermatovenerol Croat; 2023 Nov; 31(2):106-109. PubMed ID: 38006373
[TBL] [Abstract][Full Text] [Related]
11. Neutrophilic dermatoses: a review of current treatment options.
Cohen PR
Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-8 overexpression is present in pyoderma gangrenosum ulcers and leads to ulcer formation in human skin xenografts.
Oka M; Berking C; Nesbit M; Satyamoorthy K; Schaider H; Murphy G; Ichihashi M; Sauter E; Herlyn M
Lab Invest; 2000 Apr; 80(4):595-604. PubMed ID: 10780675
[TBL] [Abstract][Full Text] [Related]
13. Extracutaneous involvement of pyoderma gangrenosum.
Borda LJ; Wong LL; Marzano AV; Ortega-Loayza AG
Arch Dermatol Res; 2019 Aug; 311(6):425-434. PubMed ID: 30923901
[TBL] [Abstract][Full Text] [Related]
14. The anti-inflammatory potency of biologics targeting tumour necrosis factor-α, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study.
Vossen ARJV; Ardon CB; van der Zee HH; Lubberts E; Prens EP
Br J Dermatol; 2019 Aug; 181(2):314-323. PubMed ID: 30657173
[TBL] [Abstract][Full Text] [Related]
15. Pyoderma gangrenosum with increased levels of serum cytokines.
Kozono K; Nakahara T; Kikuchi S; Itoh E; Kido-Nakahara M; Furue M
J Dermatol; 2015 Dec; 42(12):1186-8. PubMed ID: 26047254
[TBL] [Abstract][Full Text] [Related]
16. [A no scarring persistent skin lesion for 3 years pyoderma gangrenosum].
Ndour MA; Sow D; Diedhiou D; Senghor F; Diembou M; Diouf M; Faye A; Diallo IM; Barrage AL; Kabou LM; Mbaye MN; Sarr A
Pan Afr Med J; 2019; 32():198. PubMed ID: 31312310
[TBL] [Abstract][Full Text] [Related]
17. Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments.
Maronese CA; Pimentel MA; Li MM; Genovese G; Ortega-Loayza AG; Marzano AV
Am J Clin Dermatol; 2022 Sep; 23(5):615-634. PubMed ID: 35606650
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory cells, cytokines and matrix metalloproteinases in amicrobial pustulosis of the folds and other neutrophilic dermatoses.
Marzano AV; Cugno M; Trevisan V; Lazzari R; Fanoni D; Berti E; Crosti C
Int J Immunopathol Pharmacol; 2011; 24(2):451-60. PubMed ID: 21658319
[TBL] [Abstract][Full Text] [Related]
19. Pyoderma gangrenosum associated with left iliac vein compression syndrome: presentation of difficult diagnosis.
Freitas VMP; Pereira SM; Enokihara MMSES; Cestari SDCP
An Bras Dermatol; 2017; 92(5 Suppl 1):129-131. PubMed ID: 29267470
[TBL] [Abstract][Full Text] [Related]
20. Tofacitinib in pyoderma gangrenosum - A case series.
Sathyanarayana VA; Roy D; Nagaraju B; Rao VKR
Int J Rheum Dis; 2024 Jan; 27(1):e14810. PubMed ID: 37395471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
